Hidden post-fabrication evolution of triple-cation perovskite solar cells controlled by annealing
Mendeleev Communications · 2027 · 37
DOI: 10.71267/mencom.8093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mendeleev Communications, online erschienen am 23.10.2026. Verfasst von Natalia Nikolaevna Udalova und 5 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
In perovskite solar cells (PSCs) based on triple-cation perovskite films containing 30 mol% methylammonium chloride (MACl), a hidden effect was identified, namely, the dependence of stability on annealing: insufficient thermal annealing at 100 °C leads to delayed degradation of the perovskite phase, while annealing at 125 °C for 60 min ensures the highest long-term dark storage stability of PSCs over 433 days. It was concluded that optimized annealing is not merely a crystallization step, but a key parameter determining stability and controlling hidden post-fabrication processes in MACl-assisted perovskite devices.
Förderung
- Russian Science Foundation
Zitieren
APA
Udalova, N. N., Marchenko, E. I., Wang, C., Belich, N. A., Goodilin, E. A., & Tarasov, A. B. (2027). Hidden post-fabrication evolution of triple-cation perovskite solar cells controlled by annealing. Mendeleev Communications, 37. https://doi.org/10.71267/mencom.8093
Vancouver
Udalova NN, Marchenko EI, Wang C, Belich NA, Goodilin EA, Tarasov AB. Hidden post-fabrication evolution of triple-cation perovskite solar cells controlled by annealing. Mendeleev Communications. 2027;37. doi:10.71267/mencom.8093
BibTeX
@article{Udalova2027,
author = {Udalova, Natalia Nikolaevna and Marchenko, Ekaterina Igorevna and Wang, Chengyuan and Belich, Nikolay Andreevich and Goodilin, Eugene Alekseevich and Tarasov, Aleksei Borisovich},
title = {Hidden post-fabrication evolution of triple-cation perovskite solar cells controlled by annealing},
journal = {Mendeleev Communications},
year = {2027},
volume = {37},
doi = {10.71267/mencom.8093}
}
EUVIMED